ArticleTherapeutic advances in medical oncology2022

Comparison of afatinib and erlotinib combined with bevacizumab in untreated stage IIIB/IV epidermal growth factor receptor-mutated lung adenocarcinoma patients: a multicenter clinical analysis study.

Suey-Haur Lee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.